About: Combating COVID-19 with integrated traditional Chinese and Western medicine in China

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Combating COVID-19 with integrated traditional Chinese and Western medicine in China Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Combating COVID-19 with integrated traditional Chinese and Western medicine in China
Creator	Chen, Lili Zhang, Hong Chen, Hongzhuan Han, Chouping Luan, Xin Ni, Liqiang Q7, Q8 Xu, Jianguang Yuan, Weian Zhao, Yongfang
Source	Elsevier; Medline; PMC
abstract	COVID-19, an acute respiratory infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread throughout the world. China has achieved initial success in containing this highly infectious disease with integrated traditional Chinese and Western medicine. Current findings have shown that the Chinese protocol can reduce the incidence of severe or critical events, improve clinical recovery and help alleviate symptoms such as cough or fever. The inclusion of traditional Chinese medicine (TCM) in this protocol is based on its successful experience in fighting against pestilence. To date there are 133 ongoing registered clinical studies on TCM/integrated traditional Chinese and Western medicine. Although there are no high-quality clinical evidences, pharmacological studies have suggested that Chinese medicine is effective for COVID-19 probably through its host-directed regulation and certain antiviral effects.
has issue date	2020-06-27(xsd:dateTime)
bibo:doi	10.1016/j.apsb.2020.06.009
bibo:pmid	32834946
has license	no-cc
sha1sum (hex)	c27fdc3939c29acb9d1dcb2904a3ba73f6610cf9
schema:url	https://doi.org/10.1016/j.apsb.2020.06.009
resource representing a document's title	Combating COVID-19 with integrated traditional Chinese and Western medicine in China
has PubMed Central identifier	PMC7319939
has PubMed identifier	32834946
schema:publication	Acta Pharm Sin B
resource representing a document's body	covid:c27fdc3939c29acb9d1dcb2904a3ba73f6610cf9#body_text
is schema:about of	named entity 'traditional Chinese medicine (TCM)' named entity 'traditional Chinese' named entity 'severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)' named entity 'suggested' named entity 'effects' named entity 'recovery' named entity 'symptoms' named entity 'incidence' named entity 'pharmacological' named entity 'Western medicine' named entity 'fever' named entity 'infectious disease' named entity 'severe acute respiratory syndrome coronavirus 2' named entity 'clinical studies' named entity 'cough' named entity 'SARS-CoV-2' named entity 'Western medicine' named entity 'COVID-19' named entity 'natural product' named entity 'pathogens' named entity 'clinicaltrials.gov' named entity 'LPS' named entity 'traditional Chinese medicine' named entity 'pathogens' named entity 'human medicine' named entity 'public transportation' named entity 'clinical trials' named entity 'molecular docking' named entity 'Hubei University' named entity 'mechanism of action' named entity 'SARS-CoV' named entity 'clinical trial' named entity '2019 Novel Coronavirus' named entity 'eradication of smallpox' named entity 'Traditional Chinese Medicine' named entity 'China' named entity 'virus' named entity 'holistic' named entity 'TCM' named entity 'gastrointestinal tract' named entity 'RCTS' named entity 'lopinavir/ritonavir' named entity 'COVID-19' named entity 'mechanism of action' named entity 'COVID-19' named entity 'ephedrine' named entity 'anti-inflammatory' named entity 'Chinese medicine' named entity 'transaminase' named entity 'China' named entity 'preventing disease' named entity 'China' named entity 'Chinese medicine' named entity 'cough' named entity 'COVID' named entity 'Formononetin' named entity 'CET' named entity 'hydroxychloroquine' named entity 'heart tissue' named entity 'COVID' named entity 'liquiritin' named entity 'Arbidol' named entity 'virus' named entity 'SARS-CoV' named entity 'antiviral effect' named entity 'pathogens' named entity 'virus' named entity 'inflammatory factors' named entity 'portal vein' named entity 'Chinese medicine' named entity 'etiological' named entity 'modern medicine'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software